Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 32, 1997 - Issue 12
Submit an article Journal homepage
14
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Interferon-α2b Therapy in Low-Activity Hepatitis C: A Pilot Study

I. Nordøy Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
H. B. Krarup Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
H. Bell Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
P. B. Christensen Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
K. Elgjo Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
B. Von Der Lippe Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
O. Schaffalitzky De Muckadell Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
A. Mæland Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
H. Ring Larsen Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
H. H. Samdal Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
P. Simmonds Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
K. Skaug Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
,
U. Tage Jensen Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark
&
E. Schrumpf Medical Dept. A and Dept. of Pathology, Rikshospitalet, Oslo, Norway; Medical Dept., Aker University Hospital, Oslo, Norway; Medical Dept., Ullevål Hospital, Oslo, Norway; National Institute of Public Health, Oslo, Norway; Dept. of Medical Gastroenterology and Dept. of Clinical Chemistry, Aalborg Hospital, Aalborg, Denmark; Dept. of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark; Medical Dept. A, Rigshospitalet, Copenhagen, Denmark; Dept. of Medical Microbiology, University of Edinburgh, Edinburgh, UK
 show all
Pages 1256-1260 | Received 11 Jun 1997, Accepted 07 Sep 1997, Published online: 08 Jul 2009

References

  • Chamaya K., Saitoh S., Arase Y., Ikeda K., Matsumoto T., Sakai Y., et al. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 1991; 13: 1040–3
  • Varagona G., Brown D., Kibbler H., Scheuer P., Ashrafzadeh P., Sherlock S., et al. Respone, relapse and retreatment rates and viremia in chronic hepatitis C treated with α2b interferon. A phase III study. Eur J Gastroenterol Hepatol 1992; 4: 707–12
  • Hagiwara H., Hayashi N., Mita E., Takehara T., Kasahara A., Fusamoto H., et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993; 104: 877–83
  • Douglas D. D., Rakela J., Lin H. J., Hollinger F. B., Taswell H. F., Czaja A. J., et al. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C: comparison of alanine aminotransferase normalization versus loss of HCV-RNA and anti-HCV IgM. Dig Dis Sci 1993; 38: 601–7
  • Chemello L., Cavaletto L., Noventa F., Bonetti P., Casarin C., Bernardinello E., et al. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C with interferon-α. J Viral Hepatitis 1995; 2: 91–6
  • Tsubita A., Chayama K., Ikeda K., Yasuji A., Koida I., Saitoh S., et al. Factors predictive of response to interferon-alpha therapy in hepatitis C infection. Hepatology 1994; 19: 1088–94
  • Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899–905
  • Booth J. C L, Brown J. L., Thomas H. C. The managment of chronic hepatitis C virus infection. Gut 1995; 37: 449–54
  • Esteban Jl, Lopez-Talvera J. C., Genesca J., Madoz P., Viladomiu L., Muniz E., et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443–9
  • Alberti A., Morsica G., Chemello L., Cavaletto D., Noventa F., Pontisso P., et al. Hepatitis C viremia and liver in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697–8
  • Nordøy I., Schrumpf E., Elgjo K., Flesland O., Andersen Glende J., ørjasæter H., et al. Liver disease in anti-hepatitis C virus-positive Norwegian blood donors. Scand J Gatroenterol 1994; 29: 77–81
  • Naito M., Hayashi N., Hagiwara H., Hiramatsu N., Kasahara A., Fusamoto H., et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19: 871–5
  • Hoofnagle J. H., Di Bisceglie A. M. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347–56
  • van Thiel D. H., Caraceno P., Molloy P. J., Hassanein T., Kania R. J., Gurakar A., et al. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon α2b therapy. J Hepatol 1995; 23: 503–8
  • Serfaty L., Chazouillères O., Pawlotsky J. M., Andreani T., Pellet C., Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistenly normal aminotransferase activity. Gastroenterology 1996; 110: 291–5
  • Ideo G., Bellobuono A., Tempini S., Bellati G., Romano L., Zanetti A. R. Interferon treatment of chronic hepatitis C patients with normal or near normal alanine-amino-tranferase levels: might it be harmful rather than useful?. Int Hepatol Comm 1996; 6: 8–15
  • Sangiovanni A., Spinzi G. C., Ceriani R., Prada A., Bissoli F., Morales R., et al. Randomized controlled trial of HCV healthy carriers treatment with interferon (IFN) [abstract]. Hepatology 1995; 22(Suppl 4)290A
  • Salmerón J., Perez-Ruiz M., Palacios A., Caballero T., Torres C., Bellot V., et al. Interferon (IFN) alpha treatment of chronic hepatitis C (CHC) with normal vs elevated alanine aminotransferase (ALT) levels [abstract]. J Hepatol 1995; 23(Suppl 1)105
  • Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–9
  • Stuyver L., Rossau R., Wyseur A., Duhamel M., Vanderborght B., van Heuverswyn H., et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093–102
  • Garson J. A., Ring C. J A, Tuke P. W. Improvement of HCV genome detection with ‘short’ PCR products. Lancet 1991; 338: 1466–7
  • Bjøro K., Frøland S. S., Yun Z., Samdal H. H., Haaland T. HCV infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globuline. N Eng J Med 1994; 331: 1607–11
  • Davidson F., Simmonds P., Ferguson J. C., Jarvis L. M., Dow B. C., Follett A. C., et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 1197–204
  • Review by an International Group. Acute and chronic hepatitis revisited. Lancet 1977; 2: 914–9
  • Scheuer P. J., Ashrafzadeh P., Sherlock S., Brown D., Dusheiko G. M. The pathology of hepatitis C. Hepatology 1992; 15: 567–71
  • Bach N., Thung S. N., Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic active hepatitis: a comparative analysis. Hepatology 1992; 15: 572–7
  • Hagiwara H., Hayashi N., Kasahara A., Oshita M., Katayama K., Kato M., et al. Treatment with recombinant interferon α2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Scand J Gastroenterol 1996; 31: 1021–6
  • Tsubota A., Kumasa H., Chayama K., Arase Y., Saitoh S., Koida I., et al. Relationship between pretreatment viremia level and response to interferon-α therapy in chronic hepatitis C differs in viral type 1 and 2 infection. Dig Dis Sci 1996; 41: 1925–32
  • Kanai K., Kako M., Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543
  • Yoshioka K., Kakumu S., Wakita T., Ishikawa T., Hoh Y., Takayanagi M., et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–9
  • Takada N., Takase S., Enomoto N., Takada A., Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol 1992; 14: 35–40
  • Chemello L., Alberti A., Rose K., Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994; 330: 143
  • Brechot C. Hepatitis C virus genetic variability: clinical implications. Am J Gastroenterol 1994; 89: S41–7
  • Young K. K Y, Resnick R. M., Myers T. W. Detection of hepatitis C virus RNA by a combined transcription polymerase chain reaction assay. Clin Microbiol 1993; 31: 882–6
  • Bell H., Helium K., Hartug S., Mæland A., Ritland S., Myrvang B., et al. Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Scand J Infect Dis 1996; 28: 357–9
  • Yano M., Kumada H., Kage M., Ikeda K., Shimamatsu K., Inoue O., et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.